Sergamumo Ir Pirmalaikio Mirtingumo Nuo Kraujotakos Sistemos Ligų Mažinimo Krypties Aprašas

Objectives

Reduce cardiovascular and circulatory-system disease morbidity and premature mortality, especially among people aged under 64 and residents of target territories with substantial health inequalities, through coordinated action ending in 2022 and outcome targets extending to 2023.[1][2][3]The strategic aim is to improve prevention, risk-factor management, early diagnosis, timely treatment, rehabilitation and equitable access to high-quality services, enabling people to remain healthy, independent and economically active for longer.[1][4]

• Prioritise municipalities where average standardised cardiovascular mortality among people aged 0–64 was at least 20% above the national average in 2007–2011, while allowing later expansion to other territories after target-area outcomes are achieved.[1]
• Reduce standardised cardiovascular mortality among people aged 0–64 in target territories from 158.91 to 105 deaths per 100,000 population by 2023, and increase participation in the Lithuanian Cardiovascular Disease Prevention Programme from 22.3% in 2012 to 40% in 2023.[3]
• Address smoking, hypertension, dyslipidaemia, unhealthy diet, salt intake, obesity, physical inactivity, alcohol-related harm and work-related stress, recognising persistent dyslipidaemia and inadequate lipid management as major concerns.[5][6][7][8]
• Promote healthy nutrition by reducing saturated fat, salt and sugar and increasing fibre, fruit and vegetables, including wider public understanding and voluntary use of the “Keyhole” healthy-food symbol.[9][10]
• Strengthen primary prevention for people without symptoms and secondary prevention for people with established disease, aiming to reduce disease progression, disability, repeat hospitalisation, revascularisation procedures, surgery and premature death while improving quality of life.[11][12][13]
• Improve emergency and specialist care for myocardial infarction, heart failure, atrial fibrillation and other acute cardiovascular conditions, including timely access to vessel-opening treatment and reduced regional inequalities in cardiology care.[14][15][16]
• Expand secondary-level outpatient cardiology services nearer to patients’ homes, reduce average waiting times in target areas from 19 days in 2013 to 15 days in 2023, and improve access through mobile and remote care.[17][18]
• Modernise healthcare infrastructure, diagnostic capacity, less invasive treatment technologies, e-health systems and the skills of the health workforce, while improving service quality, accessibility, sustainability and efficiency.[19][20][21]

Implementation

Implement an integrated, multi-level model combining targeted action in high-mortality territories, support for residents in those territories and national health-system measures to secure consistent, accessible cardiovascular care across regions and care levels.[22]The model links public health, primary care, secondary and tertiary cardiology, emergency services, community provision and electronic information exchange, with common clinical standards and continuity of treatment.[11][23][24]

• Develop integrated operating models between primary healthcare institutions and municipal public health bureaux to promote health, provide individual counselling and monitor people at cardiovascular risk.[23][7]
• Deliver prevention through family medicine providers, specialised cardiology services, public health bureaux, communities, non-governmental organisations, employers, education institutions and the food industry; encourage physical activity, healthier diets, smoking cessation and workplace stress reduction.[8][6][7]
• Expand the Ministry of Health-funded cardiovascular screening and prevention programme beyond its existing target group of women aged 50–65 and men aged 40–55 without cardiovascular disease, using family medicine institutions to identify and invite eligible patients.[8][25]
• Establish or strengthen specialised prevention and heart-failure clinics, delivering multidisciplinary diagnosis, treatment, continuing care, medication management, palliative care, patient education and coordination across inpatient and outpatient settings.[12][4]
• Apply standardised, evidence-based diagnostic and treatment algorithms for atherosclerotic cardiovascular disease, acute coronary syndromes, atrial fibrillation and heart failure, adapted to each level of care and supported by regular updating and data transfer.[26][16]
• Provide mobile cardiology teams and remote consultations in territories without permanent outpatient cardiologists, and strengthen emergency medical services, patient transport, nationally consistent emergency algorithms and ambulance capacity.[27][28]
• Train family doctors, nurses, cardiologists, emergency personnel, public health specialists, social workers and other professionals in prevention, risk assessment, early diagnosis, treatment, multimorbidity, electronic consultation and lifestyle interventions.[29][30][31]
• Improve electronic referrals, interoperable patient information, telemedicine, wearable-device use, patient-flow management and electronic recording of circulatory diseases, so family doctors and cardiologists can access relevant clinical information.[24][32]
• Assign implementation across the Ministry of Health and subordinate institutions, the National Health Insurance Fund, the Health Education and Disease Prevention Centre, the Institute of Hygiene, municipal administrations, public health bureaux, healthcare providers, universities, university hospitals, professional associations and community organisations.[23][33][32][34]
• Monitor mortality, programme participation, lifestyle risks, cardiology access, waiting times, telemedicine and mobile-service activity, service use, training and clinical outcomes; assess outcome indicators in 2019 and 2023 and review measures accordingly.[35][18][21]
• Use up to 85 million Lithuanian litas allocated to this action-plan direction, alongside Compulsory Health Insurance Fund financing that reflects planned service expansion; assess prior European Union and other-funded investments before further infrastructure procurement or modernisation.[36][21]

Monitoring & Evaluation

The framework combines population health surveillance, service-delivery monitoring and periodic review to track reductions in circulatory-system morbidity and premature mortality, particularly in target territories and among people aged under 64.[2][35][3]It also recognises material limitations in heart-failure mortality and repeat-hospitalisation data.[37]

• Monitor standardised circulatory-system mortality among people aged 0–64 years, including the target-area reduction from 158.91 to 105 deaths per 100,000 population by 2023.[35][3]
• Track participation in the Lithuanian Cardiovascular Disease Prevention Programme, with a planned increase from 22.3% in 2012 to 40% in 2023.[35][3]
• Measure lifestyle and risk-factor outcomes, including fruit and vegetable consumption, low physical activity, daily smoking, overweight and obesity.[35][38]
• Monitor service access and quality through outpatient cardiology visits, waiting times, tertiary referrals, secondary-level service availability, telemedicine and mobile-service activity, time to angioplasty, and 30-day survival after myocardial infarction.[35][18][3][38]
• Track programme participation, risk-factor prevalence, treatment needs, referrals and municipal service delivery; reported programme data for 2009–2012 show reductions in hypertension, metabolic syndrome, body mass index and abdominal obesity, but persistent dyslipidaemia and increased smoking.[8][39][25]
• Develop continuous municipality-level monitoring of smoking, overweight and physical inactivity to assess public health bureau effectiveness, with responsibilities assigned to the Ministry of Health or subordinate institutions, municipal administrations and public health bureaux.[40]
• Use Institute of Hygiene mortality data and National Health Insurance Fund data sources, while recognising that death-registration practice does not permit reliable estimation of mortality among people with heart failure and that official repeat-hospitalisation statistics were unavailable.[14][37]
• Review implementation criteria annually, assess outcome-indicator achievement in 2019 and 2023, and revise planned measures in response to findings.[21]

Operational responsibilities are allocated for specified actions to the Ministry of Health, its subordinate institutions, the State Health Insurance Fund, universities, healthcare providers, municipalities and public health bureaux.[23][30][41][24]However, the source does not specify a complete plan-wide reporting cycle, surveillance governance structure, evaluation methodology or formal accountability framework.[26][32][18]

Costing & Financing

Financing relies principally on Ministry of Health funding, the Compulsory Health Insurance Fund and European Union Structural Funds, with investment intended to expand access, modernise infrastructure and improve efficiency.[8][42][36][21]The action-plan direction has an allocation of up to 85 million Lithuanian litas, while other cited investments support regional cardiology projects and public health infrastructure.[36][19][43][44]

• Allocate up to 85 million Lithuanian litas to implement measures under the action-plan direction.[36]
• Finance the cardiovascular disease screening and prevention programme through the Ministry of Health, while taking account of service expansion in Compulsory Health Insurance Fund budgeting.[8][36]
• Use 83.4 million Lithuanian litas from the 2004–2006 European Union Structural Funds for the Eastern Cardiology Project and 156.4 million Lithuanian litas from the 2007–2013 funds for the central and western Lithuania cardiovascular project.[19][43]
• Invest more than 15 million Lithuanian litas in municipal public health bureau infrastructure during 2007–2013.[44]
• Assess prior infrastructure, utilisation and results from European Union and other-funded investments made in 2004–2006 and 2007–2013 before committing further modernisation or procurement finance.[21]
• Aim to deliver more services with unchanged health insurance resources, or maintain service volumes with fewer resources, and avoid duplicate financing for shared cardiovascular and cerebrovascular risk-factor measures.[36][21]
• Recognise heart failure and repeat hospitalisation as an economic burden; other European and American countries allocate up to 3% of health budgets to heart-failure care, while Lithuania’s 2013 expenditure is not quantified.[15]

The source identifies additional resource needs for programme expansion, data analysis, coordination, equipment, ambulances, training, electronic health solutions and cardiologist recruitment, but does not specify unit costs, national co-financing, quantified funding gaps or wider economic assumptions.[25][27][41][28][24]